0001883850-22-000040.txt : 20220411
0001883850-22-000040.hdr.sgml : 20220411
20220411180129
ACCESSION NUMBER: 0001883850-22-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220407
FILED AS OF DATE: 20220411
DATE AS OF CHANGE: 20220411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 22820678
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-04-07
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
Common Stock
2022-04-07
4
M
0
1500
399.66
A
30244
D
Common Stock
2022-04-07
4
F
0
1175
716.09
D
29069
D
Common Stock
2022-04-08
4
S
0
16
724.33
D
29053
D
Common Stock
2022-04-08
4
S
0
30
728.77
D
29023
D
Common Stock
2022-04-08
4
S
0
16
729.67
D
29007
D
Common Stock
2022-04-08
4
S
0
44
733.38
D
28963
D
Common Stock
2022-04-08
4
S
0
43
735.12
D
28920
D
Common Stock
2022-04-08
4
S
0
29
739.02
D
28891
D
Common Stock
2022-04-08
4
S
0
28
740.98
D
28863
D
Common Stock
2022-04-08
4
S
0
32
743.71
D
28831
D
Common Stock
2022-04-08
4
S
0
56
744.52
D
28775
D
Common Stock
2022-04-08
4
S
0
31
745.27
D
28744
D
Common Stock
2022-04-08
4
M
0
6000
381.92
A
34744
D
Common Stock
2022-04-08
4
F
0
4586
736.21
D
30158
D
Common Stock
2022-04-08
4
M
0
2000
399.66
A
32158
D
Common Stock
2022-04-08
4
F
0
1552
736.21
D
30606
D
Common Stock
2022-04-11
4
S
0
74
729.76
D
30532
D
Common Stock
2022-04-11
4
S
0
37
731.6
D
30495
D
Common Stock
2022-04-11
4
S
0
22
732.56
D
30473
D
Common Stock
2022-04-11
4
S
0
1226
733.52
D
29247
D
Common Stock
2022-04-11
4
S
0
75
734.53
D
29172
D
Common Stock
2022-04-11
4
S
0
149
735.36
D
29023
D
Common Stock
2022-04-11
4
S
0
189
736.61
D
28834
D
Common Stock
2022-04-11
4
S
0
22
737.89
D
28812
D
Common Stock
2022-04-11
4
S
0
68
738.63
D
28744
D
Common Stock
229
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
381.92
2022-04-08
4
M
0
6000
0.0
D
2026-12-16
Common Stock
6000
12800
D
Non-Qualified Stock Option (right to buy)
399.66
2022-04-07
4
M
0
1500
0.0
D
2024-12-16
Common Stock
1500
2000
D
Non-Qualified Stock Option (right to buy)
399.66
2022-04-08
4
M
0
2000
0.0
D
2024-12-16
Common Stock
2000
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 44 shares of Company stock on April 8, 2022 at prices ranging from $733.28 to $733.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price.
Represents volume-weighted average price of sales of 43 shares of Company stock on April 8, 2022 at prices ranging from $735.06 to $735.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price.
Represents volume-weighted average price of sales of 32 shares of Company stock on April 8, 2022 at prices ranging from $743.48 to $743.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price.
Represents volume-weighted average price of sales of 74 shares of Company stock on April 11, 2022 at prices ranging from $729.63 to $729.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Represents volume-weighted average price of sales of 37 shares of Company stock on April 11, 2022 at prices ranging from $731.57 to $731.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Represents volume-weighted average price of sales of 22 shares of Company stock on April 11, 2022 at prices ranging from $732.00 to $732.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Represents volume-weighted average price of sales of 1,226 shares of Company stock on April 11, 2022 at prices ranging from $733.40 to $733.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Represents volume-weighted average price of sales of 75 shares of Company stock on April 11, 2022 at prices ranging from $734.08 to $734.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Represents volume-weighted average price of sales of 149 shares of Company stock on April 11, 2022 at prices ranging from $735.02 to $735.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
Represents volume-weighted average price of sales of 189 shares of Company stock on April 11, 2022 at prices ranging from $736.40 to $736.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2022-04-11